South Africa is rapidly moving to protect its highly valued healthcare workers through the Sisonke Study. The WHO reports that healthcare workers are an especially vulnerable group.
An open label, pragmatic, real world Phase 3b clinical trial of the investigational single-dose Janssen COVID-19 vaccine candidate among frontline healthcare workers in South Africa